JPY 9750.0
(-0.61%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 21.4 Billion | 7.61 Billion | 10.4 Billion | 9.85 Billion | 13.26 Billion | 7.15 Billion |
Net Income | 6.3 Billion | 4.74 Billion | 8.86 Billion | 8.65 Billion | 5.86 Billion | 1.33 Billion |
Depreciation & Amortization | 7.27 Billion | 6.72 Billion | 5.13 Billion | 5.58 Billion | 5.34 Billion | 5.43 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 5.88 Billion | -985 Million | 533 Million | -1.6 Billion | 3.12 Billion | 1.7 Billion |
Other non-cash items | 15.48 Billion | -2.88 Billion | -4.11 Billion | -2.78 Billion | -1.06 Billion | -1.31 Billion |
Investing Cash Flow | -13.03 Billion | -17.88 Billion | -9.62 Billion | -7 Billion | -5.67 Billion | -8.5 Billion |
Investments in PPE | -12.42 Billion | -17.45 Billion | -9.98 Billion | -6.94 Billion | -5.53 Billion | -6.74 Billion |
Acquisitions | 2 Million | 9 Million | 235 Million | 79 Million | 268 Million | -1.59 Billion |
Investment purchases | -258 Million | -26 Million | -30 Million | -30 Million | -232 Million | -215 Million |
Sales/Maturities of investments | 25 Million | 5 Million | 40 Million | -49 Million | -36 Million | 71 Million |
Other Investing Activities | -371 Million | -423 Million | 116 Million | -58 Million | -135 Million | -18 Million |
Financing Cash Flow | -4.98 Billion | 9.37 Billion | 897 Million | -2.43 Billion | -7.5 Billion | 2.32 Billion |
Debt repayment | -4.66 Billion | -2.97 Billion | -2.59 Billion | -3.13 Billion | -4.08 Billion | -2.76 Billion |
Dividends payments | -403 Million | -403 Million | -403 Million | -376 Million | -350 Million | -352 Million |
Common Stock Repurchased | - | - | - | - | -323 Million | -243 Million |
Common Stock Issuance | 87 Million | - | - | - | -2.74 Billion | 7 Million |
Other Financing Activities | -1 Million | 12.75 Billion | 3.89 Billion | 1.07 Billion | -1 Million | 5.67 Billion |
Accounts receivables | 6 Million | -28 Million | 2 Million | -15 Million | 153 Million | 12 Million |
Accounts payables | 1.22 Billion | 2.22 Billion | 1.13 Billion | -1.6 Billion | 2.49 Billion | 944 Million |
Inventory | -219 Million | -1.46 Billion | -722 Million | -432 Million | 121 Million | 105 Million |
Other working capital | 4.86 Billion | -1.72 Billion | 115 Million | 448 Million | 350 Million | 641 Million |
Cash at beginning of period | 8.63 Billion | 9.54 Billion | 7.85 Billion | 7.44 Billion | 7.36 Billion | 6.38 Billion |
Cash at end of period | 12.02 Billion | 8.63 Billion | 9.54 Billion | 7.85 Billion | 7.44 Billion | 7.36 Billion |
Capital Expenditure | -12.42 Billion | -17.45 Billion | -9.98 Billion | -6.94 Billion | -5.53 Billion | -6.74 Billion |
Effect of forex changes on cash | - | -1 Million | - | - | -1 Million | - |
Net cash flow / Change in cash | 3.39 Billion | -910 Million | 1.68 Billion | 411 Million | 83 Million | 979 Million |
Free Cash Flow | 8.98 Billion | -9.84 Billion | 425 Million | 2.9 Billion | 7.72 Billion | 407 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.11 Billion | 6.3 Billion | 1.7 Billion | 1.25 Billion | 1.23 Billion | 4.74 Billion |
Depreciation & Amortization | - | 7.27 Billion | - | 1.78 Billion | 1.73 Billion | 6.72 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 5.88 Billion | - | - | - | -985 Million |
Other non-cash items | -2.11 Billion | 15.48 Billion | -1.7 Billion | -1.25 Billion | -1.23 Billion | -2.88 Billion |
Investing Cash Flow | - | -13.03 Billion | - | - | - | -17.88 Billion |
Investments in PPE | - | -12.42 Billion | - | - | - | -17.45 Billion |
Acquisitions | - | 2 Million | - | - | - | 9 Million |
Investment purchases | - | -258 Million | - | - | - | -26 Million |
Sales/Maturities of investments | - | 25 Million | - | - | - | 5 Million |
Other Investing Activities | - | -371 Million | - | - | - | -423 Million |
Financing Cash Flow | - | -4.98 Billion | - | - | - | 9.37 Billion |
Debt repayment | - | -4.66 Billion | - | - | - | -2.97 Billion |
Dividends payments | - | -403 Million | - | - | - | -403 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 87 Million | - | - | - | - |
Other Financing Activities | - | -1 Million | - | - | - | 12.75 Billion |
Accounts receivables | - | 6 Million | - | - | - | -28 Million |
Accounts payables | - | 1.22 Billion | - | - | - | 2.22 Billion |
Inventory | - | -219 Million | - | - | - | -1.46 Billion |
Other working capital | - | 4.86 Billion | - | - | - | -1.72 Billion |
Cash at beginning of period | - | 8.63 Billion | - | 7.82 Billion | 8.63 Billion | 9.54 Billion |
Cash at end of period | - | 12.02 Billion | - | 9.74 Billion | 7.82 Billion | 8.63 Billion |
Capital Expenditure | - | -12.42 Billion | - | - | - | -17.45 Billion |
Effect of forex changes on cash | - | - | - | - | - | -1 Million |
Net cash flow / Change in cash | - | 3.39 Billion | - | 1.91 Billion | -806 Million | -910 Million |
Free Cash Flow | - | 8.98 Billion | - | 3.56 Billion | 3.46 Billion | -9.84 Billion |
MED
0MN5
688268
3297
CPHI
JEGI